PROLONGATION OF MURINE VASCULARIZED HEART ALLOGRAFT SURVIVAL BY RECIPIENT-SPECIFIC ANTI-MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II ANTIBODY1
作者:
Smith2,3 Richard,
Chen4 Zhonghua,
Foulkes5 Roly,
Metcalfe4 Su,
Wraith6 David,
期刊:
Transplantation
(OVID Available online 1997)
卷期:
Volume 64,
issue 3
页码: 525-528
ISSN:0041-1337
年代: 1997
出版商: OVID
数据来源: OVID
摘要:
Background.Antibodies targeting recipient major histocompatibility complex (MHC) class II molecules have been demonstrated to be effective at prolonging allograft survival. However, antigen-presenting cell depletion would explain this effect and has not been definitively excluded as the mechanism of action of such antibodies. We have studied an anti-MHC class II antibody (OX6) proven to be noncytotoxic in the recipient strain used.Methods.Antibody was administered the day before, 2 hr before, and the day after grafting.Results.Antibody administration on the day before, 2 hr before, and the day after grafting significantly prolonged vascularized cardiac allograft survival. Importantly, treatment recognizing recipient MHC was effective, whereas a similar regimen recognizing donor MHC was not.Conclusions.Noncytotoxic recipient MHC class II-specific antibodies modify allograft rejection. Possible mechanisms for this therapeutic effect are discussed.
返 回